KYMR – kymera therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Kymera Therapeutics, Inc. (NASDAQ: KYMR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Kymera Therapeutics, Inc. (NASDAQ: KYMR) had its "outperform" rating re-affirmed by analysts at Leerink Partners. They now have a $60.00 price target on the stock.
Why Is Kymera Therapeutics (KYMR) Up 10.9% Since Last Earnings Report? [Yahoo! Finance]
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
Kymera upgraded, MoonLake downgraded: Wall Street's top analyst calls [Yahoo! Finance]
Form 4 Kymera Therapeutics, For: Sep 17 Filed by: Esposito Pamela
Form 144 Kymera Therapeutics, Filed by: Esposito Pamela
Form 4 Kymera Therapeutics, For: Aug 26 Filed by: Albers Jeffrey W.
Form 144 Kymera Therapeutics, Filed by: Horobin Joanna
Form 144 Kymera Therapeutics, Filed by: Albers Jeffrey W.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.